» Articles » PMID: 36672162

Using Single-Cell RNA Sequencing and MicroRNA Targeting Data to Improve Colorectal Cancer Survival Prediction

Overview
Journal Cells
Publisher MDPI
Date 2023 Jan 21
PMID 36672162
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer has proven to be difficult to treat as it is the second leading cause of cancer death for both men and women worldwide. Recent work has shown the importance of microRNA (miRNA) in the progression and metastasis of colorectal cancer. Here, we develop a metric based on miRNA-gene target interactions, previously validated to be associated with colorectal cancer. We use this metric with a regularized Cox model to produce a small set of top-performing genes related to colon cancer. We show that using the miRNA metric and a Cox model led to a meaningful improvement in colon cancer survival prediction and correct patient risk stratification. We show that our approach outperforms existing methods and that the top genes identified by our process are implicated in NOTCH3 signaling and general metabolism pathways, which are essential to colon cancer progression.

Citing Articles

Application of single cell sequencing technology in ovarian cancer research (review).

Yuan Q, Lv N, Chen Q, Shen S, Wang Y, Tong J Funct Integr Genomics. 2024; 24(5):144.

PMID: 39196391 PMC: 11358195. DOI: 10.1007/s10142-024-01432-w.


Survival prediction landscape: an in-depth systematic literature review on activities, methods, tools, diseases, and databases.

Abbasi A, Asim M, Ahmed S, Vollmer S, Dengel A Front Artif Intell. 2024; 7:1428501.

PMID: 39021434 PMC: 11252047. DOI: 10.3389/frai.2024.1428501.


Single-cell transcriptomics reveals stage- and side-specificity of gene modules in colorectal cancer.

Rahiminejad S, Mukund K, Maurya M, Subramaniam S Res Sq. 2024; .

PMID: 38826219 PMC: 11142301. DOI: 10.21203/rs.3.rs-4402565/v1.


Deciphering colorectal cancer progression features and prognostic signature by single-cell RNA sequencing pseudotime trajectory analysis.

Bazyari M, Saadat Z, Firouzjaei A, Aghaee-Bakhtiari S Biochem Biophys Rep. 2023; 35:101491.

PMID: 37601456 PMC: 10439350. DOI: 10.1016/j.bbrep.2023.101491.


Regulatory Roles of Non-Coding RNAs in Cancer.

Silva-Cazares M, Perez-Plasencia C, Lopez-Camarillo C Cells. 2023; 12(9).

PMID: 37174698 PMC: 10177348. DOI: 10.3390/cells12091298.


References
1.
Kigel B, Rabinowicz N, Varshavsky A, Kessler O, Neufeld G . Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling. Blood. 2011; 118(15):4285-96. DOI: 10.1182/blood-2011-03-341388. View

2.
Yu W, Imoto I, Inoue J, Onda M, Emi M, Inazawa J . A novel amplification target, DUSP26, promotes anaplastic thyroid cancer cell growth by inhibiting p38 MAPK activity. Oncogene. 2006; 26(8):1178-87. DOI: 10.1038/sj.onc.1209899. View

3.
Pancho A, Aerts T, Mitsogiannis M, Seuntjens E . Protocadherins at the Crossroad of Signaling Pathways. Front Mol Neurosci. 2020; 13:117. PMC: 7339444. DOI: 10.3389/fnmol.2020.00117. View

4.
Guo J, Wang S, Jiang Z, Tang L, Liu Z, Cao J . Long Non-Coding RNA RFPL3S Functions as a Biomarker of Prognostic and Immunotherapeutic Prediction in Testicular Germ Cell Tumor. Front Immunol. 2022; 13:859730. PMC: 9165694. DOI: 10.3389/fimmu.2022.859730. View

5.
Shinmura K, Igarashi H, Kato H, Koda K, Ogawa H, Takahashi S . BSND and ATP6V1G3: Novel Immunohistochemical Markers for Chromophobe Renal Cell Carcinoma. Medicine (Baltimore). 2015; 94(24):e989. PMC: 4616546. DOI: 10.1097/MD.0000000000000989. View